The role of mu-opioid receptors (MORs) in the inflammatory pain processing mechanisms within the ventrobasal complex of the thalamus (VB) is not well understood. This study investigated the effect of modulating MOR activity upon nociception, by stereotaxically injecting specific ligands in the VB. Nociceptive behaviour was evaluated in two established animal models of inflammatory pain, by using the formalin (acute and tonic pain) and the ankle-bend (chronic monoarthritic pain) tests. Control (saline intra-VB injection) formalin-injected rats showed acute and tonic pain-related behaviours. In contrast, intrathalamic administration of , N-Me-Phe 4 , Gly 5 -ol]-enkephalin acetate (DAMGO), a MOR-specific agonist, induced a statistically significant decrease of all tonic phase pain-related behaviours assessed until 30-35 min after formalin hind paw injection. In the acute phase only the number of paw-jerks was affected. In monoarthritic rats, there was a noticeable antinociceptive effect with approximately 40 min of duration, as denoted by the reduced ankle-bend scores observed after DAMGO injection. Intra-VB injection of D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH 2 (CTOP), a specific MOR antagonist, or of CTOP followed, 10 min after, by DAMGO had no effects in either formalin or ankle-bend tests. Data show that DAMGO-induced MOR activation in the VB has an antinociceptive effect in the formalin test as well as in chronic pain observed in MA rats, suggesting an important and specific role for MORs in the VB processing of inflammatory pain. Ó
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Introduction
G-protein-coupled mu-opioid receptors (MORs) are required for the action of the most potent analgesics such as morphine [19] . The role of MORs in the persistence of inflammatory hyperalgesia has been highlighted by studies in knock-out mice [31, 61] . Additionally, studies in arthritic rats with long-lasting pain have shown increased MOR synthesis in the spinal cord, dorsal root ganglia and peripheral nerve terminals [56, 60, 68] . The correlation of MOR with nociceptive mechanisms has been mostly evaluated at the spinal cord level and brainstem circuits [24, 26, 29, 54, 55, 63, 66, 70, 82] . In contrast, in the thalamus only a few studies have been reported [3, 16] .
The thalamus is especially important for sensory discrimination and transmission/modulation of painful stimuli. The rat ventrobasal (VB) thalamic complex, which comprises the ventroposterolateral (VPL) and the ventroposteromedial (VPM) nuclei, is the main relay thalamic region involved in tactile sensation and medial lemniscal information to the primary somatosensory cortex [59] . The VB is also implicated in pain processing and contains nociceptive-specific neurons, as demonstrated by electrophysiology studies [22, 28, 76, 80] , and observed in our previous studies in formalin-induced inflammation [58] as well as in monoarthritis [47, 49, 57] . MORs are expressed in the VB, especially within the VPL [37] [38] [39] [40] but their role in thalamic pain-processing mechanisms is not well understood.
These mechanisms can be partly clarified by evaluating the effects on nociceptive behaviour induced by microinjection of specific MOR ligands into target regions within the central nervous system [19, 53] 
